Cargando…
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality
PURPOSE: Pseudomonas aeruginosa bacteremia presents a severe challenge to hospitalized patients. However, to date, the risk factors for mortality among inpatients with P. aeruginosa bacteremia in China remain unclear. PATIENTS AND METHODS: This retrospective multicenter study was performed to analyz...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669529/ https://www.ncbi.nlm.nih.gov/pubmed/33209041 http://dx.doi.org/10.2147/IDR.S268744 |
_version_ | 1783610592065486848 |
---|---|
author | Zhang, Yulin Li, Yi Zeng, Ji Chang, Yanzi Han, Shouhua Zhao, Jiankang Fan, Yanyan Xiong, Zhujia Zou, Xiaohui Wang, Chunlei Li, Binbin Li, Haibo Han, Jiajing Liu, Xinmeng Xia, Yudi Lu, Binghuai Cao, Bin |
author_facet | Zhang, Yulin Li, Yi Zeng, Ji Chang, Yanzi Han, Shouhua Zhao, Jiankang Fan, Yanyan Xiong, Zhujia Zou, Xiaohui Wang, Chunlei Li, Binbin Li, Haibo Han, Jiajing Liu, Xinmeng Xia, Yudi Lu, Binghuai Cao, Bin |
author_sort | Zhang, Yulin |
collection | PubMed |
description | PURPOSE: Pseudomonas aeruginosa bacteremia presents a severe challenge to hospitalized patients. However, to date, the risk factors for mortality among inpatients with P. aeruginosa bacteremia in China remain unclear. PATIENTS AND METHODS: This retrospective multicenter study was performed to analyze 215 patients with culture-confirmed P. aeruginosa bacteremia in five healthcare centers in China during the years 2012–2019. RESULTS: Of 215 patients with P. aeruginosa bacteremia, 61 (28.4%) died during the study period. Logistic multivariable analysis revealed that cardiovascular disease (OR=3.978, P=0.001), blood transfusion (OR=5.855, P<0.001) and carbapenem-resistant P. aeruginosa (CRPA) phenotype (OR=4.485, P=0.038) constituted the independent risk factors of mortality. Furthermore, both CRPA and multidrug-resistant P. aeruginosa (MDRPA) phenotypes were found to be significantly associated with 5-day mortality (Log-rank, P<0.05). CONCLUSION: This study revealed a high mortality rate amongst hospitalized patients with P. aeruginosa bacteremia, and those with cardiovascular diseases, CRPA and MDRPA phenotypes, should be highlighted and given appropriate management in China. |
format | Online Article Text |
id | pubmed-7669529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-76695292020-11-17 Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality Zhang, Yulin Li, Yi Zeng, Ji Chang, Yanzi Han, Shouhua Zhao, Jiankang Fan, Yanyan Xiong, Zhujia Zou, Xiaohui Wang, Chunlei Li, Binbin Li, Haibo Han, Jiajing Liu, Xinmeng Xia, Yudi Lu, Binghuai Cao, Bin Infect Drug Resist Original Research PURPOSE: Pseudomonas aeruginosa bacteremia presents a severe challenge to hospitalized patients. However, to date, the risk factors for mortality among inpatients with P. aeruginosa bacteremia in China remain unclear. PATIENTS AND METHODS: This retrospective multicenter study was performed to analyze 215 patients with culture-confirmed P. aeruginosa bacteremia in five healthcare centers in China during the years 2012–2019. RESULTS: Of 215 patients with P. aeruginosa bacteremia, 61 (28.4%) died during the study period. Logistic multivariable analysis revealed that cardiovascular disease (OR=3.978, P=0.001), blood transfusion (OR=5.855, P<0.001) and carbapenem-resistant P. aeruginosa (CRPA) phenotype (OR=4.485, P=0.038) constituted the independent risk factors of mortality. Furthermore, both CRPA and multidrug-resistant P. aeruginosa (MDRPA) phenotypes were found to be significantly associated with 5-day mortality (Log-rank, P<0.05). CONCLUSION: This study revealed a high mortality rate amongst hospitalized patients with P. aeruginosa bacteremia, and those with cardiovascular diseases, CRPA and MDRPA phenotypes, should be highlighted and given appropriate management in China. Dove 2020-11-12 /pmc/articles/PMC7669529/ /pubmed/33209041 http://dx.doi.org/10.2147/IDR.S268744 Text en © 2020 Zhang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Yulin Li, Yi Zeng, Ji Chang, Yanzi Han, Shouhua Zhao, Jiankang Fan, Yanyan Xiong, Zhujia Zou, Xiaohui Wang, Chunlei Li, Binbin Li, Haibo Han, Jiajing Liu, Xinmeng Xia, Yudi Lu, Binghuai Cao, Bin Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title | Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_full | Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_fullStr | Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_full_unstemmed | Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_short | Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_sort | risk factors for mortality of inpatients with pseudomonas aeruginosa bacteremia in china: impact of resistance profile in the mortality |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669529/ https://www.ncbi.nlm.nih.gov/pubmed/33209041 http://dx.doi.org/10.2147/IDR.S268744 |
work_keys_str_mv | AT zhangyulin riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT liyi riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT zengji riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT changyanzi riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT hanshouhua riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT zhaojiankang riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT fanyanyan riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT xiongzhujia riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT zouxiaohui riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT wangchunlei riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT libinbin riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT lihaibo riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT hanjiajing riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT liuxinmeng riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT xiayudi riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT lubinghuai riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT caobin riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality |